Methyl 2-(2-bromophenyl)-2-hydroxyacetate, 98%, 1g

2-Bromo-5-fluoro-4-methoxyaniline, 97%, 10g

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine, 95.0%, 10g

3-Chloro-6-(4-chlorophenyl)pyridazine, 97%, 5g

2-(Pyridin-2-ylthio)ethanol, 97%, 1g

1-(2-aminoethyl)-5-(3-fluorobenzyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 1g

4,5-DIMETHYL-1,3-DIOXOLAN-2-ONE, 95%, 1g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 300m2/g)25g

5-(difluoromethyl)-1,3,4-thiadiazol-2-amine, 95+%, 250mg

2-Butanol, min. 98.5%, for synthesis, 25 l, plastic packaging.

4-Benzyloxyphenylacetic acid, 98.0%, 5g

4-(tert-Butyl)benzamide, 97.0%, 50g

trans-4-(Difluoromethoxy)cyclohexane-1-carboxylic acid, 98%, 100mg